PHIA Koninklijke Philips N.V.

Philips demonstrates innovation leadership in MR at RSNA

Philips demonstrates innovation leadership in MR at RSNA

December 2, 2019

  • One million patient scans accelerated with Compressed SENSE
  • Philips and the University Medical Center of Leiden (LUMC) jointly top performer in the multi-coil tracks with 8x acceleration category of the fastMRI image reconstruction challenge, organized by Facebook AI Research (FAIR) and NYU Langone Health
  • Second team in which Philips participated, together with the University of Amsterdam (UvA), the Amsterdam University Medical Center (Amsterdam UMC), and Radboud University, was top performer in the single-coil track with 4x acceleration category

Chicago, U.S. and Amsterdam, the Netherlands (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted its latest advances in MR to help increase productivity, improve the patient and staff experience, and enhance diagnostic confidence. The company recently marked the completion of its one millionth patient scan accelerated with Compressed SENSE, an advanced solution that reduces exam times by up to 50% [1]. At the , Philips is also highlighting its Ambition 1.5T MR platform, the industry’s first and only commercially available fully sealed magnet for more productive, helium-free operations [2].

“Our accelerated Compressed SENSE scanning technology, combined with a host of smart, AI-powered innovations, enables a step-change in MR speed, productivity and workflow, while improving the experience for patients and staff,” said Arjen Radder, General Manager for MR at Philips. “At RSNA we’re also showcasing our breakthrough platform with its fully-sealed BlueSeal magnet, which has received an enthusiastic reception from healthcare providers worldwide since its launch last year.”

Yesterday, it was that Philips and the Leiden University Medical Center (LUMC) were together the top performer in the image reconstruction challenge in the multi-coil tracks with 8x acceleration category. A second team in which Philips participated, together with the University of Amsterdam (UvA), the Amsterdam University Medical Center (Amsterdam UMC), and Radboud University, was the top performer in the single-coil track with 4x acceleration category. The fastMRI challenge is a collaborative research project between Facebook AI Research (FAIR) and NYU Langone Health. The aim is to investigate the use of AI to make MRI scans up to 10 times faster. By producing accurate images from under-sampled data, AI image reconstruction has the potential to improve the patient’s experience and make MRI exams accessible for more people. Results will be presented leading AI conference in Vancouver on December 14.

Faster scanning times increase productivity while benefitting patients and staff

is helping imaging providers to reshape their practices. For example, by replacing two older MR systems with the speed and quality of a single Philips 1.5T MR system with Compressed SENSE, the Diagnostic Imaging Center in Boynton Beach, Florida, U.S. has been able to consolidate operations into a single building, saving nearly USD 500,000 a year in total costs [3]. In Japan, Kurashiki Central Hospital’s Director of Radiological Technology and Vice President of the Japan Association of Radiological Technologists, Dr Masayuki Kumashiro, highlights the positive impact that the technology has on the staff experience: “The shorter scan times achieved with Compressed SENSE relieve the stress of a tight work schedule for the MR staff,” said Kumashiro. “Technologists can spend the gained time on increasing the image quality, or to take more time for patient preparation and dealing with safety aspects.”

SmartWorkflow solutions driving a breakthrough in workflow experience

Improving MR speed and workflow is a key area of attention for imaging providers. Combining powerfully with Compressed SENSE, Philips’ latest SmartWorkflow solution integrates guided patient setup and scanning automation, along with AI-embedded technology including VitalEye, VitalScreen and SmartExam [4], helping to save time and reduce staff stress by simplifying the number of workflow steps.

When the patient is ready, Philips SmartWorkflow allows the technologist to initiate the exam with a single touch. Scanning begins immediately after the door is closed, and the system automatically centers, plans, scans, and processes the resulting images. As a result, patient setup can be done in less than one minute, even for less experienced operators [5]. With this breakthrough in workflow, a fully automated MR exam is now one step closer.

Industry-first and only fully sealed magnet receives customer and industry recognition

Incorporating Philips’ breakthrough BlueSeal fully-sealed magnet, the 1.5T MR is the world’s first MR system to realize helium-free operations [2], reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply. The fully-sealed system does not require a vent pipe and is around 900kg lighter than its predecessor [6], significantly reducing the siting challenges presented by conventional magnets and lowering construction costs.

“The Hospitales Universitarios San Roque saved about EUR 80,000 (USD 89,000) in siting costs with Ambition 1.5T MR,” said Dr María del Mar Travieso Aja, Head of Diagnostic Imaging Services at the hospital. “Our safety procedures for patients and staff are simplified. We also avoided issues with the quench pipe exit location as the hospital is situated in a quiet area.” The Ambition 1.5T MR was also recently recognized by the U.S. Association for Medical Imaging Management (AHRA), .

Philips is demonstrating its integrated portfolio of imaging solutions at the 2019 Radiological Society of North America (RSNA) Annual Meeting in booth #6730. For more Philips news from RSNA click and follow for #RSNA19 live updates.

[1] Using Compressed SENSE technology and compared to Philips exams without Compressed SENSE.

[2] The Ambition 1.5T contains less than 0.5% of the helium of a conventional system and this is permanently sealed inside the device.

[3] Results from case studies are not predictive of results in other cases, which may vary.

[4] SmartExam is not available to patients with MR Conditional Implants.

[5] Based on in-house testing.

[6] Compared to the 1.5T ZBO magnet.

For further information, please contact:

Mark Groves

Philips Global Press Office

Tel.:

Email:

Twitter:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

 

Attachments

EN
02/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch